Rheumatoid Arthritis Market is expected to increase from $56.6 billio Rheumatoid Arthritis Market 2020 | Page 10

Table 15: Rheumatoid Arthritis, Therapeutics Market, Spain, Market Forecast, 2013–2020 118
Table 16: Rheumatoid Arthritis, Therapeutics Market, Japan, Market Forecast, 2013–2020 118
Table 17: Abbreviations 119

List of Figures
Figure 1: American College of Rheumatology Treatment Guidelines, 2012 15
Figure 2: Rheumatoid Arthritis Market, Global, Annual Sales of Remicade ($bn), 2008–2013 24
Figure 3: Rheumatoid Arthritis Market, Global, Annual Sales of Humira ($bn), 2008–2013 26
Figure 4: Rheumatoid Arthritis Market, Global, Annual Sales of Enbrel ($bn), 2008–2013 27
Figure 5: Rheumatoid Arthritis Market, Global, Annual Sales of Rituxan ($bn), 2008–2013 28
Figure 6: Rheumatoid Arthritis Market, Global, Annual Sales of Orencia ($m), 2008–2013 30
Read Complete Report with TOC @ http://www.radiantinsights.com/research/rheumatoidarthritis-market-to-2020-a-crowded-market-characterized-by-modest-growth
Figure 7: Rheumatoid Arthritis Market, Global, Annual Sales of Simponi ($m), 2008–2013 31
Figure 8: Rheumatoid Arthritis Market, Global, Annual Sales of Cimzia ($m), 2008–2013 32
Figure 9: Rheumatoid Arthritis Market, Global, Annual Sales of Actemra ($m), 2008–2013 34
Figure 10: Comparative Efficacy and Safety of Marketed Products 36
Figure 11: Rheumatoid Arthritis Market, Global, Pipeline, 2014 39
Figure 12: Rheumatoid Arthritis Market, Global, Pipeline by Mechanism of Action, 2014 41
Figure 13: Rheumatoid Arthritis Market, Global, Pipeline, Cytokine Inhibitors, 2014 42
Figure 14: Rheumatoid Arthritis Market, Global, Pipeline, Inhibitors of B and T cells, 2014 43
Figure 15: Rheumatoid Arthritis Market, Global, Pipeline, Intracellular Kinase Inhibitors, 2014 44
Figure 16: Rheumatoid Arthritis, Global, Clinical Trial Failure Rate, 2006–2014 45
Figure 17: Rheumatoid Arthritis, Global, Clinical Trial Failure Rate, 2006–2014 46
Figure 18: Rheumatoid Arthritis, Global, Clinical Trial Failure Rate, 2006–2014 47